Consider this article in the Wall Street Journal on increased prescription drug prices last year, despite the “Great Recession.” Obviously, the drug makers are trying to get their licks in now before the health care overhaul takes effect, despite transparent denials by their various spokespeople. This serves as yet another example of the difficulty of [...]
Welcome to the january 12th, 2009 edition of the Festival of Stocks, hosted this week by the Enlightened American site. Below, you’ll find a selection of posts covering a wide array of topics in investing and personal finance. You can find more information on the Festival of Stocks here. More on this topic (What's this?) [...]
Click here to view the spreadsheet containing all disclosures for my complete equity portfolio, including initial entry points, YTD returns, total returns, etc. THE ENLIGHTENED-AMERICAN PORTFOLIO SPREADSHEET Enlightened-American Portfolio: -13.6% YTD (including dividends) DJIA: -29.7% Nasdaq: -35.1% S&P 500: -34.0% DJ WIlshire 5000: -34.1% Russell 2000 (smallcap): -29.8% Ten months through the year and all I [...]
In their 13F-HR filing for Q2 2008, Bruce Berkowitz and his cohorts at the Fairholme Fund continue their shift from energy into healthcare: More on this topic (What's this?) Is Pfizer (PFE) a value trap for investors? (Dividend Growth Investor, 7/21/08) Pfizer: Time to Invest? (Contrarian Profits, 6/27/08) Pfizer: How Low Will It Go? (A [...]
Bruce Berkowitz and his team at Fairholme have been keeping busy with several new additions. Quick thoughts: I am not sure if my scripts are handling the options correctly but since the options have the same CUSPID as the underlying stock, it is hard to tell which options the manager(s) are holding. Berkowitz has call [...]
Now that the portfolio page is updated, I can mention that I sold Johnson & Johnson (JNJ) earlier this month (check the portfolio page for details). We made a small gain on it but mostly it was a portfolio allocation and strategy issue. My girlfriend actually made the call to sell (I do all of [...]
